DP068 | ANTI-CD19 CAR-T IS EFFECTIVE IN SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA REFRACTORY TO HIGH-DOSE METHOTREXATE-BASED CHEMOTHERAPY
Introduction: Secondary involvement of the CNS is a complication of large B cell lymphomas (LBCL). Treatment of SCNSL differs from systemic lymphomas and is based on high dose chemotherapy (CHT) with drugs that penetrate the blood-brain barrier, HDMTX in particular, followed by autologous stem cell...
Gorde:
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Ferrata Storti Foundation
2025-09-01
|
| Saila: | Haematologica |
| Sarrera elektronikoa: | https://haematologica.org/article/view/12722 |
| Etiketak: |
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
